[96a5a0]: / output / allTrials / identified / NCT03013491_identified.json

Download this file

475 lines (475 with data), 21.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
{
"info": {
"nct_id": "NCT03013491",
"official_title": "An Open-Label, Dose-Finding and Proof of Concept Study of the PD-L1 Probody™ Therapeutic , CX-072, as Monotherapy and in Combination With Yervoy (Ipilimumab) or With Zelboraf (Vemurafenib) in Subjects With Advanced or Recurrent Solid Tumors or Lymphomas",
"inclusion_criteria": "1. Histologically confirmed diagnosis of metastatic or advanced unresectable tumors that progressed on standard therapy\n2. Agreement to provide mandatory archival tissue or fresh biopsy.\n3. At least 18 years of age.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "1. Prior therapy with a chimeric antigen receptor (CAR) T-cell containing regimen.\n2. History of severe allergic or anaphylactic reactions to human monoclonal antibody therapy or known hypersensitivity to any Probody therapeutic.\n3. Active or history of uveal, mucosal, or ocular melanoma. Human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS)-related illness, chronic hepatitis B or C.\n4. History of or current active autoimmune diseases, including but not limited to inflammatory bowel diseases, rheumatoid arthritis, autoimmune thyroiditis, autoimmune hepatitis, systemic sclerosis, systemic lupus erythematosus, autoimmune vasculitis, autoimmune neuropathies, or type 1 insulin dependent diabetes mellitus.\n5. History of syndrome or medical condition(s) that requires systemic steroids (> 10 mg daily prednisone equivalents) or immunosuppressive medications.\n6. History of allogeneic tissue/solid organ transplant, prior stem cell or bone marrow transplant.\n7. Chemotherapy, biochemotherapy, radiation or immunotherapy or any investigational treatment within 30 days prior to receiving any study drug.\n8. Major surgery (requiring general anesthesia) within 3 months or minor surgery (excluding biopsies conducted with local/topical anesthesia) or gamma knife treatment within 14 days (with adequate healing) of administration of any study drug.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Histologically confirmed diagnosis of metastatic or advanced unresectable tumors that progressed on standard therapy",
"criterions": [
{
"exact_snippets": "Histologically confirmed diagnosis",
"criterion": "diagnosis confirmation",
"requirements": [
{
"requirement_type": "method",
"expected_value": "histologically"
}
]
},
{
"exact_snippets": "metastatic or advanced unresectable tumors",
"criterion": "tumor stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"metastatic",
"advanced unresectable"
]
}
]
},
{
"exact_snippets": "tumors that progressed on standard therapy",
"criterion": "tumor progression",
"requirements": [
{
"requirement_type": "progression",
"expected_value": "progressed on standard therapy"
}
]
}
]
},
{
"line": "2. Agreement to provide mandatory archival tissue or fresh biopsy.",
"criterions": [
{
"exact_snippets": "Agreement to provide mandatory archival tissue or fresh biopsy.",
"criterion": "archival tissue or fresh biopsy",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
}
]
}
]
},
{
"line": "3. At least 18 years of age.",
"criterions": [
{
"exact_snippets": "At least 18 years of age.",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Prior therapy with a chimeric antigen receptor (CAR) T-cell containing regimen.",
"criterions": [
{
"exact_snippets": "Prior therapy with a chimeric antigen receptor (CAR) T-cell containing regimen.",
"criterion": "prior therapy",
"requirements": [
{
"requirement_type": "type",
"expected_value": "chimeric antigen receptor (CAR) T-cell containing regimen"
}
]
}
]
},
{
"line": "2. History of severe allergic or anaphylactic reactions to human monoclonal antibody therapy or known hypersensitivity to any Probody therapeutic.",
"criterions": [
{
"exact_snippets": "History of severe allergic or anaphylactic reactions to human monoclonal antibody therapy",
"criterion": "severe allergic or anaphylactic reactions",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "cause",
"expected_value": "human monoclonal antibody therapy"
}
]
},
{
"exact_snippets": "known hypersensitivity to any Probody therapeutic",
"criterion": "hypersensitivity",
"requirements": [
{
"requirement_type": "cause",
"expected_value": "Probody therapeutic"
}
]
}
]
},
{
"line": "3. Active or history of uveal, mucosal, or ocular melanoma. Human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS)-related illness, chronic hepatitis B or C.",
"criterions": [
{
"exact_snippets": "Active or history of uveal, mucosal, or ocular melanoma.",
"criterion": "melanoma",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"uveal",
"mucosal",
"ocular"
]
},
{
"requirement_type": "status",
"expected_value": [
"active",
"history"
]
}
]
},
{
"exact_snippets": "Human immunodeficiency virus (HIV)",
"criterion": "HIV",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "acquired immune deficiency syndrome (AIDS)-related illness",
"criterion": "AIDS-related illness",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "chronic hepatitis B or C",
"criterion": "chronic hepatitis",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"B",
"C"
]
}
]
}
]
},
{
"line": "4. History of or current active autoimmune diseases, including but not limited to inflammatory bowel diseases, rheumatoid arthritis, autoimmune thyroiditis, autoimmune hepatitis, systemic sclerosis, systemic lupus erythematosus, autoimmune vasculitis, autoimmune neuropathies, or type 1 insulin dependent diabetes mellitus.",
"criterions": [
{
"exact_snippets": "History of or current active autoimmune diseases",
"criterion": "autoimmune diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "inflammatory bowel diseases",
"criterion": "inflammatory bowel diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "rheumatoid arthritis",
"criterion": "rheumatoid arthritis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "autoimmune thyroiditis",
"criterion": "autoimmune thyroiditis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "autoimmune hepatitis",
"criterion": "autoimmune hepatitis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "systemic sclerosis",
"criterion": "systemic sclerosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "systemic lupus erythematosus",
"criterion": "systemic lupus erythematosus",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "autoimmune vasculitis",
"criterion": "autoimmune vasculitis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "autoimmune neuropathies",
"criterion": "autoimmune neuropathies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "type 1 insulin dependent diabetes mellitus",
"criterion": "type 1 insulin dependent diabetes mellitus",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "5. History of syndrome or medical condition(s) that requires systemic steroids (> 10 mg daily prednisone equivalents) or immunosuppressive medications.",
"criterions": [
{
"exact_snippets": "History of syndrome or medical condition(s) that requires systemic steroids",
"criterion": "syndrome or medical condition",
"requirements": [
{
"requirement_type": "treatment",
"expected_value": [
"systemic steroids"
]
}
]
},
{
"exact_snippets": "systemic steroids (> 10 mg daily prednisone equivalents)",
"criterion": "systemic steroid dosage",
"requirements": [
{
"requirement_type": "dosage",
"expected_value": {
"operator": ">",
"value": 10,
"unit": "mg daily prednisone equivalents"
}
}
]
},
{
"exact_snippets": "History of syndrome or medical condition(s) that requires ... immunosuppressive medications",
"criterion": "syndrome or medical condition",
"requirements": [
{
"requirement_type": "treatment",
"expected_value": [
"immunosuppressive medications"
]
}
]
}
]
},
{
"line": "6. History of allogeneic tissue/solid organ transplant, prior stem cell or bone marrow transplant.",
"criterions": [
{
"exact_snippets": "History of allogeneic tissue/solid organ transplant",
"criterion": "allogeneic tissue/solid organ transplant",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "prior stem cell or bone marrow transplant",
"criterion": "stem cell or bone marrow transplant",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "7. Chemotherapy, biochemotherapy, radiation or immunotherapy or any investigational treatment within 30 days prior to receiving any study drug.",
"criterions": [
{
"exact_snippets": "Chemotherapy, biochemotherapy, radiation or immunotherapy or any investigational treatment within 30 days prior to receiving any study drug.",
"criterion": "prior treatment",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"chemotherapy",
"biochemotherapy",
"radiation",
"immunotherapy",
"investigational treatment"
]
},
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 30,
"unit": "days"
}
}
]
}
]
},
{
"line": "8. Major surgery (requiring general anesthesia) within 3 months or minor surgery (excluding biopsies conducted with local/topical anesthesia) or gamma knife treatment within 14 days (with adequate healing) of administration of any study drug.",
"criterions": [
{
"exact_snippets": "Major surgery (requiring general anesthesia) within 3 months",
"criterion": "major surgery",
"requirements": [
{
"requirement_type": "time since surgery",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "months"
}
}
]
},
{
"exact_snippets": "minor surgery (excluding biopsies conducted with local/topical anesthesia) ... within 14 days",
"criterion": "minor surgery",
"requirements": [
{
"requirement_type": "time since surgery",
"expected_value": {
"operator": "<",
"value": 14,
"unit": "days"
}
}
]
},
{
"exact_snippets": "gamma knife treatment within 14 days",
"criterion": "gamma knife treatment",
"requirements": [
{
"requirement_type": "time since treatment",
"expected_value": {
"operator": "<",
"value": 14,
"unit": "days"
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}